myotwin

Happy to have our first listing in the #NonAnimalTechnologies (NAT) Database: https://lnkd.in/eH27z_vZ We’re thrilled to be part of a movement that prioritizes innovation while reducing reliance on animal testing. Our commitment to advancing humanized models means we can help build better, safer drugs more efficiently. Together, we’re shaping a future where science aligns with ethical practices. Join us on this journey! 🌱 #3R #NonAnimalTesting #DrugDevelopment

Happy to have our first listing in the #NonAnimalTechnologies (NAT) Database: https://lnkd.in/eH27z_vZ We’re thrilled to be part of a movement that prioritizes innovation while reducing reliance on animal testing. Our commitment to advancing humanized models means we can help build better, safer drugs more efficiently. Together, we’re shaping a future where science aligns with ethical practices. Join us on this journey! 🌱 #3R #NonAnimalTesting #DrugDevelopment

Looking forward to a second great day at Festival of Biologics in #Basel! So far it’s been great talks, discussions with potential partners and meetings with friends from #Göttingen 😊 Swing by our booth *S57* to learn more about what myotwin can do to accelerate your development pipeline.

Meet us in Basel 🤝🚀 We’re happy to share that myotwin is exhibiting at the Festival of Biologics in #Basel after a successful time at CPHI. 🎉 It’s the perfect chance to meet new collaborators and catch up with old friends. If you’re attending, let’s connect and explore how we can innovate together in the world of #biologics and #CVD. Drop by and say hello—we can’t wait to see you there! 💙

Meet us in Basel 🤝🚀 We’re happy to share that myotwin is exhibiting at the Festival of Biologics in #Basel after a successful time at CPHI. 🎉 It’s the perfect chance to meet new collaborators and catch up with old friends. If you’re attending, let’s connect and explore how we can innovate together in the world of #biologics and #CVD. Drop by and say hello—we can’t wait to see you there! 💙

myotwin in Milan - At the Heart of Pharma! ❤️ Thrilled to be in Milan 🇮🇹 for CPHI with the myotwin team! This event is an amazing opportunity to meet and connect with key players in the #pharma and #biotech sectors. Over the next three days, we’re looking forward to engaging conversations and exploring new partnerships that could shape the future of cardiovascular and cardio metabolic drug development. 👩🔬🔬 If you’re here, come say hi at Booth #6SU31. Let’s chat about how we can work together to create innovative solutions. Excited to see what unfolds and meet some incredible people along the way! #cardiovascularresearch #animalfreemodels #cardiotox #cphimilan

Exciting Update: myotwin Recognized at CPHI Pharma Awards 2024! 🏆 We are delighted to share that myotwin has been shortlisted in the Startup category for the esteemed CPHI Pharma Awards 2024 alongside these other incredible #startups Cocoon Bioscience, Nebu~Flow ,Axom, Oryl Photonics and Galvita AG ! This acknowledgment underscores our dedication to revolutionizing cardiac research and innovation within the biopharmaceutical industry. Join us at CPHI Milan 2024, from October 8th-10th, where we'll be presenting our innovative in vitro technology. Visit Us at CPHI Milan Booth: 6SU31 in the Excipients area Meet Our Team: Andreas, Hendrik, Mariyam, and Jan! Don't miss the chance to connect with us and discover how myotwin can enhance your R&D processes. We are eager to engage with fellow innovators and explore the future of cardiac research together. We are pleased to offer our community complimentary access to CPHI 2024. Use the link in the comments to secure your ticket. We look forward to seeing you there! Who else is attending this outstanding event? #myotwin #CPHIMilan2024 #biotech #innovation #cardiacresearch #contractresearch #3R #CPHIawards

We're thrilled to announce that myotwin will be attending CPHI Milan 2024 from October 8th-10th! 🎉 We have a special offer for our community: attend CPHI 2024 for free using the link in the comments! At myotwin, we are committed to transforming cardiac research. Our pioneering in vitro technology is the first to measure all relevant parameters of heart muscle contraction in a single organoid, offering unprecedented insights into heart health and drug development. Come visit us at booth 6SU31 in the Excipients area at CPHI Milan! Meet our dedicated team—Andreas, Hendrik, Mariyam, and Jan — and find out how myotwin can accelerate your research and development processes. We can't wait to connect with you and explore the future of cardiac R&D together! Looking forward to seeing you there! Who else is attending this excellent event? #myotwin #CPHIMilan2024 #biotech #innovation #cardiacresearch #contractresearch #3R

Futuristic 💙 heart #organoids in the historical observatory in #Göttingen: Having had the pleasure last week of working with the fantastic founders’ team of the biotech company myotwin, a spinoff of the Georg-August-Universität Göttingen, I want to share today more about their tremendous approach. myotwin produces special 🧡 human heart organoids from stem cells (*iPSCs) to improve 💊 drug testing and preclinical research for pharmaceutical companies. 👩🔬    Why is their work so important? With 🏥 cardiovascular diseases claiming countless lives globally 😕 , current drug testing methods are insufficient.   myotwin’s leading technology:  ✔ speeds up and de-risks drug development 👍 ✔ reduces animal testing  ⛔ ✔ ensures human-relevant results 👨👨👧👧    Unique in its human model and ‘trinity measurement’, the team around Andreas Meyer-Borgstädt, Hendrik Windel and Jan Pietras is dedicated to enhancing #patientcare. The founders’ plans include #AI and #digitaltwin technology to advance #personalizedmedicine. 🙏 Thank you, myotwin, for the intense discussion and collaboration. I am very proud to support you as a strategic sparring partner in positioning and business building!     ▶ You are a biotech investor and want to explore more? Feel free to reach out to the team❣    ▶ You are a #biotech or #healthtech company seeking strategic clarity and business enhancement? Reach out to me and to my co-managing partner Dr. Stefan Braunewell at Synwisery.    🙏 Thank you also to our host Startup Space Göttingen and to Start2 Group, who are giving myotwin the tremendous opportunity to learn and grow professionally.      * Induced pluripotent stem cells (iPSCs) are pluripotent stem cells generated from adult cells by reprogramming. iPSCs have the same properties as embryonic stem cells, and therefore self-renew and can differentiate into all cell types of the body.     As a sidenote for the history buffs:  The observatory's first director was the famous mathematician, astronomer, and physicist Carl Friedrich Gauss. For almost 50 years, the building was the home and workplace of the renowned scholar, who was appointed to the University of Göttingen in 1807.      #startups #end2endsparring #valueai #pharma   

myotwin meets Evotec Today, as part of our fundraising journey, we had a fantastic discussion with Thomas Hanke. We spoke about our investment case and how we build an AI-based digital twin of the human heart, aimed at optimizing and de-risking cardiovascular drug development. 💔 💊 Huge thanks to Thomas for your invaluable insights, to Life Science Valley for organizing and to Life Science Factory for hosting this event. 📢 We're currently fundraising. Reach out, and join us on our journey! 💙 #digitaltwin #lifescience #drugdevelopment #CVD